SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1751MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R)Icebrg-3/20/2007
1750Myelodysplasia: The good, the fair and the ugly. Best Pract Res Clin Haematol. Icebrg-3/7/2007
1749These EPS revisions from Merrill seem significant to me .I don't own MOGN Qtom pope-2/26/2007
1748Interesting in that the complete remission rate was higher for the intensive chetuck-2/24/2007
1747Survival advantage with decitabine versus intensive chemotherapy in patients witIcebrg-2/24/2007
1746MGI PHARMA and HELSINN HEALTHCARE SA Announce Patent Extension for Aloxi(R) Injesim1-2/13/2007
1745Earnings, outlook lift MGI stock Company upbeat on top-selling drug BY CHRISTOPHIcebrg-2/10/2007
1744>>MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results Wtuck-2/7/2007
1743Whisper number for MOGN, which reports tomorrow. earningswhispers.com The stoctuck-2/6/2007
1742MOGN gets a slap on the wrist from the FDA over Gliadel wafer ads: >>WASHtuck-1/31/2007
1741Hospital Investigates New Prophylactic HPV Vaccine Science Daily — Temple UniveIcebrg-1/31/2007
1740There will be minimal impact from generic Zofran in the 1st half, while it is haWard Knutson-1/25/2007
1739MOGN has been unexpectedly strong of late. At least three companies -- Hospira,tuck-1/25/2007
1738Phase II study of low-dose decitabine in combination with imatinib mesylate in pIcebrg-1/22/2007
1737So, amazingly, some clown bought a hundred shares of my position. Maybe it'tuck-1/17/2007
1736Aesgen DID publish these results a few months before MGI bought it, so it's tuck-1/17/2007
1735MGI PHARMA Announces Publication of Phase 3 Data for Saforis(TM) (glutamine) PowIcebrg-1/17/2007
1734MGI Pharma "buy," target price reduced Friday, January 12, 2007 4:51:Icebrg-1/12/2007
1733Slides from today's presentation at JPM conference. sec.gov ErikIcebrg-1/10/2007
1732I sold calls on my MOGN position recently. I figured Lonnie wouldn't have mtuck-1/10/2007
1731MethylGene to Increase Investment in HDAC and Kinase 'c-MET' Small MolecIcebrg-12/15/2006
1730Should have noted that it remains a buy with Merrill.tom pope-12/14/2006
1729Yes, price target remains 25.tom pope-12/14/2006
1728Only $25 to $50 million?? Where is Eric pulling that figure from? MGI has reitexixi-12/14/2006
1727OK, point taken, but if it flopped, would the stock have gone up? 25 to 50 milltuck-12/14/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News